Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis

Christina Henson(University of Oklahoma Health Sciences Center), Hisham Mehanna(University of Birmingham), Daniel J. Morton(University of Oklahoma Health Sciences Center), Brian O’Sullivan, Paul Nankivell(University of Birmingham), Sujith Baliga(The Ohio State University Wexner Medical Center), James E. Bates(The University of Texas MD Anderson Cancer Center), Petr Szturz(University of Lausanne), Pierluigi Bonomo(Azienda Ospedaliero-Universitaria Careggi), William M. Lydiatt, Shao Hui Huang(University of Toronto), Ahmad K. Abou‐Foul(University of Birmingham), Anna Lee(The University of Texas MD Anderson Cancer Center), Lachlan McDowell(Peter MacCallum Cancer Centre)
Frontiers in Oncology
September 20, 2023
10.3389/fonc.2023.1263347
Cited by 31

Related Papers

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
|The Lancet|2018|1k
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
|Journal of Clinical Oncology|2013|588
Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
|Journal of Clinical Oncology|2005|448